KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Enterprise Value (2022 - 2026)

Zimmer Biomet Holdings has reported Enterprise Value over the past 18 years, most recently at -$416.0 million for Q1 2026.

  • For Q1 2026, Enterprise Value rose 69.76% year-over-year to -$416.0 million; the TTM value through Mar 2026 reached -$416.0 million, up 69.76%, while the annual FY2025 figure was -$583.8 million, 12.83% down from the prior year.
  • Enterprise Value for Q1 2026 was -$416.0 million at Zimmer Biomet Holdings, up from -$583.8 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$284.9 million in Q3 2023 and troughed at -$1.4 billion in Q1 2025.
  • A 5-year average of -$536.9 million and a median of -$416.0 million in 2026 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: crashed 257.44% in 2025 and later skyrocketed 69.76% in 2026.
  • Year by year, Enterprise Value stood at -$369.0 million in 2022, then dropped by 10.6% to -$408.1 million in 2023, then decreased by 26.78% to -$517.4 million in 2024, then decreased by 12.83% to -$583.8 million in 2025, then increased by 28.74% to -$416.0 million in 2026.
  • Business Quant data shows Enterprise Value for ZBH at -$416.0 million in Q1 2026, -$583.8 million in Q4 2025, and -$1.3 billion in Q3 2025.